J Biol Chem, Vol. 275, Issue 3, 2211-2218, January 21, 2000
Protection against Methylation-induced Cytotoxicity by DNA
Polymerase
-Dependent Long Patch Base Excision
Repair*
Julie K.
Horton,
Rajendra
Prasad,
Esther
Hou, and
Samuel H.
Wilson
From the Laboratory of Structural Biology, NIEHS, National
Institutes of Health,
Research Triangle Park, North Carolina 27709
 |
ABSTRACT |
Using a plasmid-based uracil-containing DNA
substrate, we found that the long patch base excision repair (BER)
activity of a wild-type mouse fibroblast extract was partially
inhibited by an antibody to DNA polymerase
(
-pol). This suggests
that
-pol participates in long patch BER, in addition to
single-nucleotide BER. In single-nucleotide BER, the deoxyribose
phosphate (dRP) in the abasic site is removed by the lyase activity of
-pol. Methoxyamine (MX) can react with the aldehyde of an abasic
site, making it refractory to the
-elimination step of the dRP lyase mechanism, thus blocking single-nucleotide BER. MX exposure sensitizes wild-type, but not
-pol null mouse embryonic fibroblasts, to the
cytotoxic effects of methyl methanesulfonate (MMS) and
methylnitrosourea. Expression of
-pol in the null cells restores the
ability of MX to modulate sensitivity to MMS. The
-pol null cells
are known to be hypersensitive to MMS and methylnitrosourea, and in the presence of MX (i.e. under conditions where
single-nucleotide BER is blocked) the null cells are still considerably
more sensitive than wild-type. The data are consistent with a role of
-pol in long patch BER, which helps protect cells against
methylation damage-induced cytotoxicity.
 |
INTRODUCTION |
Single base lesions in mammalian genomic DNA are repaired by the
process known as base excision repair
(BER).1 Typically, such base
lesions arise through endogenous events including spontaneous base
loss, uracil incorporation, base deamination, and base oxidation, and
also through base alkylations introduced by alkylating agents. Recent
evidence has indicated that BER in mammalian cells is mediated through
at least two subpathways that are differentiated by the repair patch
sizes and the enzymes involved and are designated as
"single-nucleotide BER" and "long patch BER" (2-10- nucleotide
patch) (1-3). The most simple single-nucleotide BER pathway is an
ordered sequential process initiated by base excision by a
monofunctional glycosylase. Removal of the deoxyribose phosphate (dRP)
in the abasic site is by the dRP lyase activity of DNA polymerase
(
-pol) (4). Single-nucleotide BER of a uracil-containing
oligonucleotide substrate can be reconstituted in vitro with
four purified human proteins: uracil-DNA glycosylase (UDG),
apurinic/apyrimidinic endonuclease (APE),
-pol, and DNA ligase I
(4), and a complex containing these enzymes can be isolated from
extracts of mammalian cells (5). In addition, genetic evidence with
-pol- and DNA ligase I-deficient mammalian cell lines indicates that
these proteins are important for the repair of alkylating agent induced
lesions (6, 7).
The choice of subpathway in BER (single-nucleotide or long patch)
depends on whether the dRP intermediate can be efficiently removed by
the
-pol lyase activity to yield a 5'-phosphorylated DNA strand
capable of serving as a substrate for DNA ligase (4, 8). When such
processing is not efficient, for example during repair of a reduced
abasic site, long patch BER can occur (9). In addition, it has been
suggested that the properties of the damage-specific DNA glycosylase
(e.g., monofunctional, exhibiting only glycosylase activity,
or bifunctional, having glycosylase and
-lyase activity) can
determine the BER subpathway (10). For BER studied in vitro,
the two subpathways can co-repair the same type of DNA lesion and
operate in the same extract (10, 11).
It is still unclear which enzymes are involved in vivo in
the various BER subpathways. Biochemical and genetic evidence indicate that, in addition to those mentioned above, 3-methyladenine DNA glycosylase, XRCC1, DNA ligase III, flap endonuclease 1 (FEN1), and
poly(ADP-ribose) polymerase are important proteins for BER and the
repair of alkylating agent-induced lesions (9, 12-17). For
single-nucleotide repair,
-pol is the polymerase of choice for the
resynthesis step (6); however,
-pol-deficient extracts are able to
perform single-nucleotide BER (11). For long patch BER, repair has been
shown to be stimulated by proliferating cell nuclear antigen which has
led to the suggestion that DNA polymerases
and/or
are involved
(1, 18). However, the role of proliferating cell nuclear antigen may be
limited to stimulation of FEN1-dependent flap cleavage
(19), and proliferating cell nuclear antigen can promote
-pol-dependent long patch repair by this mechanism (9). There is additional evidence pointing to a role of
-pol in long patch repair DNA synthesis. For example,
-pol antibody was found to
inhibit long patch repair mediated by cell extracts (9), and
-pol-deficient extracts were unable to repair a reduced AP site on a
linear DNA substrate that could be repaired by wild-type extracts (20).
Additionally, recent data indicate that
-pol plays an essential role
in the strand displacement synthesis of long patch BER (21, 22).
In this paper, we describe further analysis of the role of
-pol in
BER and dissect the contribution of
-pol in protecting cells against
the cytotoxic effects of simple methylating agents. Using wild-type
mouse embryonic fibroblast cell extracts, we find that repair of a
plasmid-based uracil-containing BER substrate by long patch BER is
partially blocked by an antibody to
-pol. Thus, this extract is
capable of both
-pol-dependent and
-pol-independent long patch BER, in addition to the single-nucleotide BER we have described previously (6). We also examined the cellular phenotype of a
-pol-dependent long patch BER deficiency in mouse
fibroblast cells. First, single-nucleotide BER was chemically blocked
by methoxyamine (MX), and then the effect of
-pol gene deletion on
cellular sensitivity to DNA-alkylating agents was examined. The results
demonstrate a role of
-pol-dependent long patch BER in
protection of cells against the cytoxicity of the monofunctional DNA-alkylating agents methyl methanesulfonate (MMS) and
methylnitrosourea (MNU).
 |
EXPERIMENTAL PROCEDURES |
Materials--
[
-32P]dCTP,
[
-32P]dATP, [
-32P]ddATP (3000 Ci/mmol), and MicroSpin S-400 HR columns were from Amersham Pharmacia
Biotech. Maxi-plasmid and polymerase chain reaction purification kits
were from Qiagen (Valencia, CA). NENSORB-20 columns were from NEN Life
Science Products. Plasmid DNA, pUC19, was prepared from cells grown in Luria broth containing 100 µg/ml ampicillin by the procedure
specified in the Qiagen plasmid kit. High performance liquid
chromatography-purified synthetic oligodeoxyribonucleotides were
obtained from Oligos Etc., Inc. (Wilsonville, OR) or Operon
Technologies, Inc. (Alameda, CA). Phenol/chloroform, T4 DNA ligase,
restriction enzymes (PstI, BamHI,
BglII, HaeIII, SphI, and
NcoI) and Dulbecco's modified Eagle's medium, GlutaMAX-1,
and minimal essential medium non-essential amino acid solution were
from Life Technologies, Inc. T4 polynucleotide kinase and terminal
deoxynucleotidyltransferase were from Promega (Madison, WI).
-Nicotinamide adenine dinucleotide, creatine phosphokinase, diTris-phosphocreatine, MMS, MNU, and MX were from Sigma-Aldrich. Fetal
bovine serum was obtained from Summit Biotechnology (Ft. Collins, CO)
and hygromycin from Roche Molecular Biochemicals. Recombinant human
-pol, FEN1, human APE, and UDG with 84 amino acids deleted from the
amino terminus were purified as described (23-25). Antiserum specific
for
-pol was raised by immunization of rabbits (26).
Cell Lines--
The cell line utilized for preparation of cell
extracts was a clone of the wild-type mouse embryonic fibroblast cell
line M
16tsA described previously (6). The wild-type mouse
fibroblasts, a clone of the isogenic
-pol null line M
19tsA (6),
and the wild-type
-pol minigene-transfected null cell line, 19/A5
(27), were routinely grown at 34 °C in a 10% CO2
incubator in Dulbecco's modified Eagle's medium supplemented with
GlutaMAX-1, 10% fetal bovine serum, and hygromycin (80 µg/ml).
Primary Xpa+/
and Xpa
/
isogenic mouse
embryonic fibroblasts (28) were obtained from Dr. Harry van Steeg
(National Institute of Public Health and Environmental Protection,
Bilthoven, The Netherlands). These cells were transformed with SV40 T
antigen as described for the wild-type and
-pol null fibroblasts
(6). Transformed Xpa fibroblasts were routinely grown at
34 °C in a 10% CO2 incubator in Dulbecco's modified
Eagle's medium supplemented with glutamine, 10% fetal bovine serum,
minimal essential medium non-essential amino acids, and hygromycin (80 µg/ml). All cells were routinely tested and found to be free of mycoplasma contamination.
Cell Extracts--
For the long patch BER assay, wild-type mouse
fibroblast cells were cultured in 150-mm dishes until near-confluent,
washed three times with Dulbecco's phosphate-buffered saline (Life
Technologies, Inc.), and harvested by scraping. Approximately 5 × 107 cells were suspended in 1 ml of buffer (5 mM NaPO4, pH 7.1, 150 mM NaCl, 2.5 mM KCl) plus protease inhibitors, aprotinin (10 µg/ml), leupeptin (0.5 µg/ml), and Pefabloc SC (10 µg/ml) supplied by Roche
Molecular Biochemicals. The suspension was subjected to five cycles of
freeze/thaw and further disrupted by sequential passage through 18- and
22-gauge needles. The resulting homogenate was centrifuged at
20,000 × g for 10 min at 4 °C. The supernatant fraction was removed, aliquoted, and stored at
80 °C. Protein concentration was measured using the Bio-Rad protein assay dye reagent.
For the AP endonuclease assay, cell extracts were prepared from
wild-type mouse fibroblasts as described previously (20).
Construction of DNA Substrate--
A partially duplex
oligonucleotide was formed by annealing a phosphorylated 12-mer
(5'-ACCGGTACUGGC-3') containing a uracil residue at position 9 and a
20-mer (5'-ACGTGCCGGTACCGGTCTAG-3'). The 12-mer (6 nmol) and 20-mer (6 nmol) were mixed in 30 µl of buffer containing 10 mM
Tris-HCl, pH 8.0, 1 mM EDTA, 250 mM NaCl, heated to 98 °C for 3 min, and then slowly cooled to room
temperature. The annealed oligonucleotide duplex was purified by
precipitation, washed twice with 70% ethanol, and resuspended in 30 µl of 10 mM Tris-HCl, pH 8.0, 1 mM EDTA. An
aliquot of this DNA was analyzed by 20% non-denaturing polyacrylamide
gel electrophoresis to confirm that annealing had occurred.
The closed circular DNA substrate containing a unique G:U base pair was
constructed according to a previously described procedure (29) with
slight modifications. Briefly, pUC19 plasmid (500 µg) was digested
with PstI (750 units) overnight at 37 °C, and the
reaction was checked for complete linearization by 1% agarose gel
electrophoresis. The reaction mixture was diluted with five volumes of
Qiagen binding buffer, and the plasmid was purified using a Qiagen-tip
500. The purified PstI-linearized pUC19 plasmid DNA (300 pmol) was ligated to the G:U base pair-containing oligonucleotide duplex (800 pmol) in a 2-ml reaction mixture containing 100 mM Tris-HCl, pH 7.5, 10 mM MgCl2,
100 mM NaCl, 1 mM dithiothreitol (DTT), 2 mM ATP, 800 units of PstI, and 250 units of T4
DNA ligase at 15 °C overnight. The ligation product was purified
using a Qiagen-tip 500 as described above and 5'-phosphorylated in a
reaction mixture (500 µl) containing 10 mM Tris-HCl, pH
8.0, 5 mM MgCl2, 100 mM NaCl, 1 mM 2-mercaptoethanol, 2.5 mM ATP, 600 units of BamHI, and 250 units of T4 polynucleotide kinase for 3 h at 37 °C. After purification by Qiagen-tip 500, the DNA was
circularized at 15 °C overnight in a 5-ml reaction mixture
containing 50 mM Tris-HCl, pH 7.5, 10 mM
MgCl2, 100 mM NaCl, 1 mM DTT, 1 mM ATP, 750 units of BamHI, 750 units of
BglII, and 300 units of T4 DNA ligase. The reaction product
was precipitated with three volumes of ethanol, washed twice with 70%
ethanol, and resuspended in 500 µl of H2O. The circular
DNA substrate was separated from linear DNA by 0.8% agarose gel
electrophoresis. A small portion (1 µl) of the sample was
electrophoresed as a marker in a separate lane. This marker, but not
the preparative sample, was visualized by UV light, to minimize
UV/ethidium bromide-induced nicking of the DNA substrate. The closed
circular DNA substrate was isolated by electroelution and purified
using a Qiagen polymerase chain reaction purification kit. The product
was eluted in 10 mM Tris-HCl, pH 7.5, and DNA was
quantified using Hoechst 33258 dye.
Long Patch BER Assay--
BER assays were performed in a
reaction mixture (11 µl) that contained 5 µg of cell extract, 1 nM closed circular DNA substrate, 50 mM Hepes,
pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 5 mM diTris-phosphocreatine, 10 units
of creatine phosphokinase, 4 mM ATP, 0.5 mM
NAD, 4 µM [
-32P]dCTP (specific activity
1 × 106 DPM/pmol), and 4 µM each dATP,
TTP, and dGTP. Alternatively, 4 µM
[
-32P]dATP (specific activity 1 × 106 DPM/pmol) was included as the labeled nucleoside
triphosphate with 4 µM each of the remaining three
unlabeled nucleoside triphosphates. After incubation at 37 °C for 60 min, the reactions were stopped by adding 1.5 µl of 0.5 M
EDTA. The samples were extracted with phenol/chloroform, and the DNA
was purified using a MicroSpin S-400 HR column and ethanol
precipitation. The DNA samples were resuspended in 8 µl of
H2O, and repair was assessed by digestion with either
HaeIII alone or with SphI + NcoI (10 units each) at 37 °C overnight. Samples were then electrophoresed on
a 20% denaturing polyacrylamide gel. Radiolabeled products were
quantified using a Molecular Dynamics PhosphorImager 450 and ImageQuant software.
3' End Labeling--
A 49-mer oligodeoxyribonucleotide
containing a uracil residue at position 21 (5) was labeled at the 3'
end by terminal deoxynucleotidyltransferase using
[
-32P]ddATP and annealed to its complementary strand
by heating the solution at 90 °C for 3 min, followed by slow cooling
to 25 °C. 32P-Labeled duplex oligodeoxynucleotide was
separated from unincorporated [
-32P]ddATP using a
NENSORB-20 column according to the manufacturer's suggested protocol.
The radiolabeled oligodeoxynucleotide was lyophilized, resuspended in
H2O, and stored at
30 °C.
Preparation of DNA Substrates for dRP Lyase and Excision
Assays--
32P-Labeled uracil containing duplex DNA (62.5 nM) was pretreated with 10 nM UDG for 20 min at
37 °C in 100 µl of buffer containing 70 mM Hepes, pH
7.4, 0.5 mM EDTA, and 0.2 mM DTT. The reaction mixture was then supplemented with 10 mM MgCl2
and APE, either 5 nM (for normal AP-DNA) or 100 nM (for MX-adducted DNA) and the incubation continued for
an additional 20 min at 37 °C. To prepare MX-adducted substrate, the
32P-labeled UDG-treated duplex oligonucleotide was mixed
with 33 mM MX in buffer containing 50 mM
KPO4, pH 7.1 and incubated at 37 °C. After 30 min, the
DNA was recovered by ethanol precipitation, lyophilized, resuspended in
water, and stored at
30 °C.
AP Endonuclease Assay--
AP endonuclease activity was assayed
in a reaction mixture (10 µl) containing 50 mM Hepes, pH
7.4, 10 mM MgCl2, 2 mM DTT, and 20 nM 32P-labeled MX-adducted DNA. The reaction
was initiated by adding the indicated concentrations of purified APE or
cell extract, and incubation was at 37 °C. Samples were withdrawn at
the indicated time periods. The reaction was terminated by transfer to
0-1 °C, and the DNA product was stabilized by addition of
NaBH4 to a final concentration of 340 mM and
incubating 30 min on ice. The stabilized DNA products were recovered by
ethanol precipitation in the presence of 0.1 µg/ml tRNA and
resuspended in 10 µl of gel loading buffer (95% formamide, 20 mM EDTA, 0.02% bromphenol blue, and 0.02% xylene cyanol).
Alternatively, the reactions were terminated without product
stabilization by the addition of an equal volume of gel loading buffer.
After incubation at 75 °C for 2 min, the reaction products were
separated by electrophoresis in a 20% polyacrylamide gel containing 8 M urea in 89 mM Tris-HCl, 89 mM
boric acid, and 2 mM EDTA, pH 8.8, and visualized by
autoradiography. To quantify the product, the gel was scanned on a
PhosphorImager 450 and the data were analyzed using ImageQuant software.
dRP Lyase Assay--
dRP lyase activity was performed in a
reaction mixture (10 µl) containing 50 mM Hepes, pH 7.4, 10 mM MgCl2, 2 mM DTT, and 20 nM pre-incised 32P-labeled normal AP-DNA or
MX-adducted DNA. The reaction was initiated by adding
-pol (0-25
nM as indicated) and incubated at 37 °C for 15 min. The
reaction was terminated by transfer to 0-1 °C, and the DNA product
was stabilized by addition of NaBH4 as described above. The
stabilized DNA products were processed as described above and
visualized by autoradiography.
Excision Assay--
The excision reaction was reconstituted in a
reaction mixture (10 µl) that contained 50 mM Hepes, pH
7.4, 2 mM DTT, 10 mM MgCl2, 0.5 mM EDTA, 2 mM ATP, 20 µM each
dATP, dGTP, dCTP, and TTP, and APE-preincised 32P-labeled
duplex oligonucleotide substrate (20 nM). The reaction was
initiated by adding 20 nM FEN1 and
-pol, as indicated in the figure legend. Incubation was at 37 °C for 30 min. The reaction was terminated by transfer to 0-1 °C, and the DNA product was stabilized by addition of NaBH4 as described above. The
stabilized DNA product was recovered by ethanol precipitation,
separated by electrophoresis, and visualized by autoradiography.
Cytotoxicity Studies--
Cytotoxicity was determined by growth
inhibition assays. It has been shown previously that SV40-transformed
mouse embryonic fibroblasts grow logarithmically and at similar rates
under the conditions of the assay (6). Cells were seeded at a density of 40,000 cells/well in six-well dishes. The following day, they were
exposed for 1 h to a range of concentrations of MMS or MNU in
growth medium without hygromycin. MMS was dissolved directly in the
medium. A stock solution of MNU was freshly-prepared in dimethyl
sulfoxide and dissolved in medium at the time of the experiment. After
1 h, the cells were washed with Hanks' balanced salt solution and
fresh medium was added. For UV irradiation (254 nm), cell monolayers
were washed twice with Hanks' balanced salt solution before UV
exposure (0-20 J/m2) in a Stratalinker model 1800 (Stratagene, La Jolla, CA), followed by addition of growth medium.
Dishes were incubated for 4-5 days at 34 °C in a 10%
CO2 incubator until untreated control cells were
approximately 80% confluent. Cells (triplicate wells for each drug
concentration) were counted by a cell lysis procedure (30), and results
were expressed as the number of cells in drug-treated wells relative to
cells in control wells (% control growth). The IC50 and
IC90 values (defined as the concentration of agent required for 50% or 90% growth inhibition compared with untreated controls) were determined from concentration-percentage of growth inhibition curves.
Cytotoxicity studies were also conducted in the presence of MX. A stock
solution of MX (1-5 M in phosphate-buffered saline) was
prepared immediately before use and NaOH added to achieve neutral pH.
MX stock solution was added to the volume of medium required for the
experiment, and the pH was re-adjusted to 7.2 by further addition of
NaOH. Dilutions of MMS or MNU were prepared in the MX-containing
medium, and cells were dosed as described above. In certain
experiments, cells were further incubated in MX-medium for up to 7 h following the 1-h alkylating agent exposure.
 |
RESULTS |
Long Patch BER on a Plasmid-based Substrate--
We used a
plasmid-based uracil-containing DNA substrate (see "Experimental
Procedures") that allows simultaneous quantification of repair by the
single-nucleotide and long patch subpathways of BER. Conditions were
standardized to measure the efficiency (kcat/Km,DNA) of
BER and involved using a limiting concentration of DNA and saturating
or near-saturating concentrations of dNTP for both single-nucleotide
and long patch BER subpathways. Restriction enzyme and electrophoretic
analysis of BER products formed with [
-32P]dCTP as the
labeled nucleoside triphosphate indicated that the level of dCMP
incorporation by wild-type cell extract into the first nucleotide of
the repair patch (SphI + NcoI fragment) was similar to dCMP incorporation into the first two nucleotides of the
repair patch (HaeIII fragment; Fig.
1A). In the HaeIII
fragment, the ratio of dCMP incorporation (first and second
nucleotide):dAMP incorporation (third nucleotide) was approximately
10:1 (data not shown). Thus, as expected from earlier work (11),
single-nucleotide BER of uracil-DNA was predominant over long
patch BER in a wild-type cell extract.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Properties of mammalian cell extract-mediated
single-nucleotide and long patch BER on a plasmid-based
uracil-containing DNA substrate. A, diagram
illustrating plasmid substrate and restriction enzyme analysis of the
[32P]dCMP-labeled repair product. The repair reaction
mixture contained [32P]dCTP, 5 µg of wild-type mouse
embryonic fibroblast cell extract, plasmid substrate, and other
components as described under "Experimental Procedures." After
incubation, the product DNA was digested either with SphI + NcoI to obtain a labeled 10-nucleotide fragment
(lane 1) or HaeIII to obtain a
6-nucleotide fragment (lane 2) and then
electrophoresed in a denaturing 20% polyacrylamide gel. An
autoradiogram is shown. The positions of the first six nucleotides in
the repair patch are indicated by numbers, and the positions
for incorporation of dCMP into the respective restriction fragments are
indicated by asterisks. B, effect of anti- -pol
rabbit serum on dCMP and dAMP incorporation into the HaeIII
fragment. The antiserum or buffer and cell extract (5 µg) were
pre-incubated as a 1:1 mixture for 30-60 min at 0-1 °C prior to
the BER incubation. dCMP incorporation is into positions 1 and 2 of the
repair patch, and is primarily a measure of single-nucleotide BER, and
dAMP incorporation is into position 3 and is a measure of long patch
BER. Bars represent the activity in the absence ( ) of
antiserum (57 × 10 6 pmol of dCMP and 6 × 10 6 pmol of dAMP incorporated/min) and the relative
incorporation with addition of anti- -pol antiserum (+). The results
shown represent the mean and standard error of three experiments.
|
|
In the experiment shown in Fig. 1B, it was found that the
combined short and long patch BER activity of the wild-type extract (incorporation of labeled dCTP into position 1 and 2 of the repair patch) as well as long patch BER activity (incorporation of labeled dATP into position 3) were both partially inhibited by a neutralizing antibody to
-pol. Non-immune serum from the same rabbit was used in
control incubations and did not inhibit single-nucleotide or long patch
BER activity (data not shown). These results indicate clearly that a
portion of long patch BER activity measured in the wild-type cell
extract is dependent upon
-pol (
75%). Taken together, these
results indicate that in addition to a role in single-nucleotide BER,
-pol also participates in long patch BER in mouse fibroblast extracts.
Use of MX to Block Single-nucleotide BER--
The primary amine of
MX is capable of reacting with the aldehydic C1' atom of the abasic
site, as illustrated in Scheme 1.
The Schiff base intermediate produced after MX attack on the C1' atom
spontaneously resolves into the stably adducted sugar molecule.
Therefore, MX treatment will render the abasic site refractory to the
-elimination step involved in the dRP lyase activity of
-pol.
This property of the MX-adducted abasic site DNA is confirmed by the
experiments illustrated in Fig. 2. Using the duplex oligonucleotide substrates shown in Fig. 2A, the
dRP lyase activity of
-pol could be detected on a APE-cleaved normal AP site, resulting in a 29-mer product (Fig. 2B,
lanes 5 and 6), but not on a
pre-incised MX-adducted AP site (lanes 2 and
3). We conclude that MX is capable of chemical deletion of
single-nucleotide BER that depends upon elimination of the dRP moiety
in the single-nucleotide gap.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Measurements of dRP lyase activity using
normal and MX-adducted DNA substrates. The reaction conditions and
product analyses are as described under "Experimental Procedures."
A, diagram of the normal and MX-adducted AP site 3'-labeled
DNA substrates generated after APE cleavage (29-mer + dRP or 29-mer + MX-dRP), respectively, and the dRP lyase product (29-mer) is shown.
B, an autoradiogram illustrating the dRP lyase activity of
-pol on MX-adducted DNA (lanes 1-3) and
normal AP site DNA (lanes 4-6). The -pol
concentrations and the positions of the substrate and product are
indicated.
|
|
It had been reported previously that MX-adducted AP sites are resistant
to cleavage by mammalian APE (31, 32). Using the normal AP site or
MX-adducted AP site substrate shown in Fig. 3A, we found that APE is able
to cleave the MX-adducted AP site, yet the turnover number of APE
acting on the MX-adducted AP site is substantially lower (
330-fold)
than that for the normal AP site (Fig. 3B). This is further
illustrated in Fig. 3C. A MX-adducted AP site is only
partially cleaved by 100 nM APE after 15 min
(lane 2), whereas under the same conditions, 5 nM APE efficiently cleaves a normal AP site
(lane 3). Next, using wild-type cell extracts, partial cleavage of a MX-adducted AP site is observed with 8 and 16 µg of cellular protein (lanes 4 and
5), yet the cleavage of a normal AP site is complete with 8 µg of protein (lane 6). In these experiments,
reaction products were not stabilized by addition of NaBH4;
therefore, the product obtained after APE-dependent cleavage of the normal AP site substrate is a 29-mer, rather that a
29-mer+dRP (Fig. 3C). Thus, incision of a MX-adducted AP
site is readily observed in cell extracts and suggests that such
cleavage can occur in the intact cell as part of the BER pathway.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Measurements of AP endonuclease activity
using MX-adducted and normal AP site DNA substrates. The reaction
conditions and product analyses are as described under "Experimental
Procedures." A, diagram of a
3'-[32P]ddAMP-labeled DNA substrate containing either the
MX-adducted or normal AP site. Enzymatic cleavage of the DNA substrate
by AP endonuclease results in (29-mer + MX-dRP or 29-mer + dRP/29-mer)
product, respectively. B, 32P-labeled
MX-adducted duplex oligonucleotide (20 nM) was incubated
with 100 nM APE at 37 °C, and aliquots were taken at the
indicated time intervals. The incision product was stabilized and
analyzed by polyacrylamide-urea gel electrophoresis. The
kcat for APE acting on a normal AP site is 10 1/s (24). C, an autoradiogram illustrating the AP
endonuclease activity of purified AP endonuclease or wild-type cell
extract on MX-adducted AP site DNA (lanes 1,
2, 4, and 5) and normal AP site DNA
(lanes 3 and 6). Incubation was at
37 °C for 15 min. The APE and cell extract concentrations and the
positions of the substrate and products are indicated. Note, under the
reaction conditions in C where the incision product was
not stabilized, cleavage of the normal AP site results in 29-mer final
product (panel C, lanes 3 and 6).
|
|
A MX-adducted AP site, pre-incised with APE, is an active substrate for
the FEN1/
-pol-mediated flap cleavage reaction of long patch BER. As
shown in Fig. 4A, neither
-pol alone (lane 2) nor FEN1 alone
(lane 3) was able to cleave the MX-adducted AP
site. The combination of
-pol and FEN1 cleaved the characteristic flap oligomer (dRP-N3) (21) from the 5' end of the
substrate molecule, resulting in predominant formation of a 26-mer
product and leaving a four-nucleotide repair patch (Fig. 4A,
lane 4). With the normal pre-incised AP site as
substrate,
-pol alone was partially able to release the dRP moiety,
resulting in a 29-mer product (Fig. 4B, lane
2), and FEN1 alone was able to release the dRP moiety plus 1 dNMP residue, resulting in a 28-mer product, and leaving a
two-nucleotide gap in the substrate (Fig. 4B,
lane 3). In agreement with previous results (33),
FEN1 could not release the dRP moiety without an additional dNMP. The
combination of
-pol and FEN1 produced the four-nucleotide gap
characteristic of long patch BER and release of the dRP-N3
oligomer and resulted in formation of a 26-mer product (Fig.
4B, lane 4). The combination of
-pol and FEN1 exhibited a similar level of activity toward the
normal dRP-containing substrate and the MX-adducted substrate. We
conclude from these results that MX adduction of the dRP moiety does
not interfere with long patch BER involving excision of the dRP-N3 oligomer.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Excision activity of
-pol and FEN1 on APE pre-incised MX-adducted and
normal AP site DNA substrates. The reaction conditions and
products analyses are described under "Experimental Procedures."
32P-Labeled 49-base pair duplex oligonucleotides (20 nM) containing MX-adducted (A) or normal AP site
DNA (B) were pre-incised with APE, then incubated with (+)
or without ( ) FEN1 (20 nM) and/or -pol (5 nM), as indicated. All reactions were at 37 °C for 30 min. The 3' end labeling was accomplished by
[ -32P]ddATP, and as a result of addition of ddAMP at
the 3' end, the APE-cleaved DNA substrate will be 29-mer + MX-dRP
(panel A) or 29-mer + dRP (panel
B). The positions of the substrate and products are
indicated. , 3'-position of 32P label on the modified
DNA strand.
|
|
Effect of MX on Methylation-induced Cytotoxicity--
To examine
any cellular role of
-pol-dependent long patch BER in
sensitivity to DNA alkylating agents, we used the approach of treatment
of cells with MX to eliminate single-nucleotide BER at the time of
exposure to the methylating agents. Modification of abasic sites in
cells by MX has been demonstrated previously to influence the cytotoxic
effects of simple alkylating agents (34). High concentration and/or
lengthy exposure to MX is equally cytotoxic to wild-type and
-pol
null cell lines, but under all of the conditions reported here, MX was
found to result in 10% or less growth inhibition (data not shown).
Co-exposure to MX was able to sensitize wild-type cells to the
cytotoxic effects of both MMS and MNU. For MMS, the effect was both
time- and concentration-dependent (Fig.
5). At a concentration of 10 mM MX, near-maximal sensitization was achieved at 4 h,
with only a slightly enhanced effect at 8 h (Fig. 5A).
The requirement for prolonged exposure to MX is consistent with the
known slow repair of cytotoxic methyl adducts and therefore the
appearance of AP sites as intermediates of BER in cells (35). For a 4-h
exposure to MX, near maximal sensitization was achieved at a
concentration of 20 mM, with an only slightly enhanced
effect at 30 mM (Fig. 5B). For both MMS (Fig. 5)
and MNU (data not shown), a similar maximal sensitization was seen for
exposures to 10 mM MX for 8 h or 30 mM for
4 h, resulting in a 25% decrease in IC50 values. We
propose that this modulation of sensitivity is a result of MX-induced
blockage of the predominant single-nucleotide BER pathway in the cells.
In contrast, in the
-pol null cells, in which single-nucleotide BER
is inefficient, there was no significant sensitization to MMS (Fig.
5C) or MNU (data not shown) by MX under the experimental
conditions (10 mM MX for 8 h and 30 mM MX
for 4 h) that were most effective in the wild-type cells. In
-pol null cells partially complemented by stable transfection of
wild-type
-pol, co-exposure to MX (30 mM for a total of
4 h) resulted in sensitization to MMS (Fig. 5D). This
result confirms that there is a requirement for
-pol, and presumably
-pol-dependent single-nucleotide repair, for the
MX-induced modulation of sensitivity.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of MX on MMS-induced
cytotoxicity. Experiments were conducted as described under
"Experimental Procedures" to produce MMS survival curves.
A, time dependence of MX-sensitization of wild-type cells.
Cells were exposed to a range of MMS concentrations for 1 h in the
absence ( ) or presence ( ) of 10 mM MX. MX incubation
was continued in certain experiments for a total of 4 h ( ) or
8 h ( ). Inset, percentage of hypersensitivity was
calculated from IC90 values with the effect at 8 h
designated as 100%. B, concentration dependence of
MX-sensitization of wild-type cells. Cells were exposed to a range of
MMS concentrations for 1 h in the absence ( ) or presence of 4 mM ( ), 10 mM ( ), 20 mM ( ),
or 30 mM ( ) MX. MX incubation was continued for a total
of 4 h. Inset, percentage of hypersensitivity was calculated from
IC90 values with the effect at 30 mM designated
as 100%. For the wild-type cells, data are from representative
experiments, values represent the mean of triplicate determinations.
C, effect of MX in -pol null cells. Cells were exposed to
a range of MMS concentrations for 1 h in the absence ( ) or
presence of 10 mM MX for a total of 8 h ( ) or 30 mM MX for a total of 4 h ( ). Values represent the
mean of two or three independent experiments; there were no significant
differences between control and MX-treated cells. D, effect
of MX in -pol-complemented -pol null cells. Cells were exposed to
a range of MMS concentrations for 1 h in the absence ( ) or
presence of 30 mM MX for a total of 1 h ( ) or
4 h ( ). Data are from a representative experiment; values
represent the mean of triplicate determinations.
|
|
We have reported previously that the
-pol null cells are not
hypersensitive to the cytotoxic effects of UV irradiation (6), suggesting that
-pol-dependent BER is not involved in
the repair of cytotoxic UV-induced DNA adducts. We now demonstrate that
neither wild-type or
-pol null cell lines were sensitized to UV
irradiation in the presence of MX (Fig.
6A). In addition, MX was not
able to sensitize cells to the DNA cross-linking nitrogen mustard
derivative, chlorambucil (data not shown). These results suggest that
the MX-induced sensitization may be specific for agents that produce cytotoxic lesions that can be repaired by BER. Xpa
/
mouse fibroblasts, deficient in nucleotide excision repair (NER) and
extremely sensitive to killing by UV irradiation (data not shown), were
found to be only slightly hypersensitive to MMS when compared with
isogenic Xpa+/
fibroblasts (Fig. 6B). These
data indicate that MMS cytotoxicity is a result of DNA adducts which
are repaired by a pathway other than NER, most likely BER. Co-exposure
to MX is able to sensitize equally both Xpa+/
and
Xpa
/
cell lines to MMS, resulting in a 40% decrease in
IC50 values (Fig. 6B). This result suggests that
NER is not involved in repair of a MX-adducted AP site in mouse
fibroblasts.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of MX on UV cytotoxicity in wild-type
and -pol null mouse fibroblasts and MMS
cytotoxicity in NER-defective fibroblasts. Survival curves were
produced as described under "Experimental Procedures."
A, wild-type (closed symbols) and
-pol null cells (open symbols) were exposed to
UV irradiation followed by a 4-h incubation in the absence ( , )
or presence ( , ) of 30 mM MX. B,
Xpa+/ (closed symbols) and
Xpa / cells (open symbols) were
exposed to a range of MMS concentrations for 1 h in the absence
( , ) or presence ( , ) of 30 mM MX. MX
incubation was continued for a total of 4 h. Data are from a
representative experiment; values represent the mean of triplicate
determinations.
|
|
We have shown previously that the
-pol null cells are
hypersensitive to the cytotoxic effects of both MMS and MNU, 2.4- and 3.7-fold, respectively, at IC50 (6). When MMS and MNU
sensitivity are compared in the presence of MX (i.e. under
conditions where there is elimination of single-nucleotide BER), the
-pol null cells are still considerably more sensitive than wild-type
cells (1.5- and 2.3-fold, respectively, for MMS and MNU at
IC50; Fig. 7). These data are
consistent with the hypothesis that, in addition to its protective
function in single-nucleotide BER,
-pol also plays a role in long
patch BER and protects cells against methylation damage-induced
cytotoxicity.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
Sensitivity of wild-type and
-pol null mouse fibroblasts to methylating agents
in the presence of MX. Survival curves were produced as described
under "Experimental Procedures." Wild-type ( ) and -pol null
( ) cells were exposed for 1 h to a range of concentrations of
MMS (A) and MNU (B) in the presence of 30 mM MX. MX incubation was continued for a total exposure
time of 4 h. The results shown represent the mean of triplicate
determinations.
|
|
 |
DISCUSSION |
In this study, we present evidence for a
-pol dependence in the
long patch BER of both a normal and a MX-adducted AP site. In addition,
the results demonstrate a role for
-pol in the long patch BER of
cytotoxic lesions produced as a result of exposure of cells to
methylating agents. It has been proposed previously that
-pol
functions specifically in wild-type cells in single-nucleotide BER (6).
However, there is increasing evidence pointing to an additional role of
-pol in a long patch BER subpathway. The long patch BER activity of
a wild-type mouse fibroblast extract was partially inhibited by a
neutralizing antibody to
-pol (Fig. 1B), clearly
demonstrating that a portion of the repair of uracil-containing DNA by
long patch BER, measured on a plasmid substrate, is dependent on
-pol. In these experiments,
-pol-dependent long patch
repair of a natural AP site is seen under conditions where
-pol-mediated single-nucleotide repair is also operative.
Previously,
-pol-dependent long patch repair has been
demonstrated under conditions where single-nucleotide repair is not operative. For example, Biade et al. (see Fig. 1C
in Ref. 20) showed that a linear DNA substrate bearing a synthetic
sugar phosphate that is refractory to the
-pol dRP lyase activity is
repaired by long patch BER by a wild-type mouse embryonic fibroblast
cell extract, but is not repaired by an extract from an isogenic cell line lacking
- pol. Similarly, Klungland and Lindahl (9)
demonstrated that long patch BER of a reduced AP site on an
oligonucleotide DNA substrate by a HeLa cell extract is strongly
inhibited by a specific neutralizing antibody to
-pol.
Recently, Dianov et al. (21) have shown that it is the
excision product release step during long patch BER of an internally labeled uracil-DNA circular substrate by a mouse fibroblast cell extract that is dependent upon
-pol. The results suggest that
-pol conducts the strand displacement synthesis of long patch BER.
Further evidence for this role of
-pol in long patch repair was
provided in the present study, by the demonstration of a requirement for
-pol, in addition to FEN1, for the flap cleavage, and therefore subsequent long patch repair, of a MX-adducted AP site (Fig. 4). In the
case of cleavage of the MX-adducted AP site as described here, it is
not known whether other polymerases could fulfill this same role in the
cell. However, in the study by Dianov and co-workers (21), excision
product release was deficient in extracts from
-pol null cells and
was inhibited in wild-type cell extracts by a
-pol neutralizing
antibody. It is likely that there is a similar requirement for
-pol
for the processing and subsequent long patch BER of a MX-adducted site.
The quantitative reaction of AP sites in DNA with MX in
vitro and its use in studies of BER have been reported previously (31, 36). MX-adducted AP sites have been found to be refractory to
-elimination (31), which would include the dRP lyase activity of
-pol as demonstrated here (Fig. 2B). Therefore, MX can
specifically block
-pol-dependent single-nucleotide
repair, but does not interfere with long patch BER (Fig.
4A). From the present and previous data, it can be predicted
that the preferred subpathway of repair of a MX-adducted AP site is
long patch BER. Indeed, long patch BER (average of 10 nucleotides per
MX-AP site) by Chinese hamster ovary cell extracts has been detected on
a multiply MX-adducted plasmid substrate (37).
We and others have shown that MX-adducted AP sites are resistant to
cleavage by APE (Fig. 3B; Refs. 31 and 32). However, incision of a MX-adducted AP site is readily observed in cell extracts
(Fig. 3C). This suggests that the APE-mediated cleavage of a
MX-adducted AP site required for BER will be functional in the intact
cell. It should be noted that approximately two-thirds or more of
endogenous AP sites, and presumably therefore AP sites produced as a
result of BER in cells, are already 5'-cleaved (38). Under these
circumstances, and presuming that MX reacts with pre-incised AP sites
as does the aldehyde reactive probe (38), the relatively inefficient
cleavage of MX-adducted AP sites by APE would not be required for long
patch BER in vivo.
In the present study, we found that MX treatment results in a
concentration- and time-dependent sensitization of
wild-type but not
-pol null cells to MMS (Fig. 5). With high
concentrations of MX (30 mM), there was an apparent small
sensitization in the
-pol null cells in certain experiments, perhaps
consistent with the low levels of single-nucleotide repair that have
been detected in extracts from these cells (11), but this sensitization
was not statistically significant. Expression of
-pol in the null cells restores the ability of MX to modulate sensitivity to MMS (Fig.
5D). We suggest that the modulation in wild-type cells is a
result of inhibition of DNA repair, specifically
-pol-dependent single-nucleotide BER. BER of
N-methyl DNA adducts produced as a result of exposure to MMS
and MNU are initiated by the monofunctional glycosylase,
N-methylpurine-DNA glycosylase (39). Base excision, as well
as spontaneous depurination, will result in formation of cytotoxic AP
sites, which, after cleavage by APE, require removal of the dRP through
the dRP lyase activity of
-pol. We show here that this lyase
activity can be chemically blocked by MX adduction of the AP site (Fig.
2B).
A slot-blot assay using an aldehyde reactive probe has been utilized to
detect AP site induction in cells following treatment with MMS (40).
Using the same 1-h MMS treatment protocol as in the cytotoxicity
studies, we were not able to detect a significant increase in AP sites
in the wild-type fibroblast
cells.2 Therefore, it has not
been possible to use this procedure to demonstrate directly that MX can
react with AP sites formed in our cells. MX has been demonstrated
previously to react with AP sites produced as a result of cell exposure
to monofunctional DNA-alkylating agents (41). In these experiments, the
presence of MX during cell treatment with diethyl sulfate has been
shown to cause a concentration- and time-dependent
inhibition of repair as assessed by alkaline elution (41).
We propose that MX-induced modulation of sensitivity is specific for
agents that produce cytotoxic lesions that can be repaired by BER and
where
-pol deficiency results in hypersensitivity. Whereas MX was
able to specifically sensitize wild-type cells to monofunctional
methylating agents that produce cytotoxic AP sites in cells (42), it
was not able to sensitize cells to chlorambucil (data not shown) or UV
irradiation (Fig. 6A). Chlorambucil initially produces DNA
lesions that could be repaired by BER (43) (
-pol null cells show low
level hypersensitivity to this agent); however, cytotoxicity is thought
to result from DNA cross-linking rather than AP site formation (43). UV
irradiation produces primarily "bulky" cytotoxic DNA adducts that
are repaired by NER rather than
-pol-dependent BER.
It has been reported that NER may be involved in the repair of a
MX-adducted AP site (44). In agreement with data demonstrating that
NER-deficient human fibroblasts, defective in repair of lesions formed
by UV irradiation, possess a normal capacity for repair following MMS
treatment (45), we show that the NER-deficient Xpa
/
cells
are only slightly hypersensitive to MMS (Fig. 6B). In
addition, we find that MX is able to sensitize NER-efficient Xpa+/
and NER-deficient Xpa
/
cells equally
to MMS (Fig. 6B), suggesting that NER is not involved in
repair of a MX-adducted AP site in mouse fibroblasts.
It has been proposed that the hypersensitivity of
-pol null cells to
monofunctional DNA-alkylating agents is a result of the deficiency in
-pol-dependent single-nucleotide repair of DNA damage
(6). We describe here that, under conditions where there is elimination
of single-nucleotide BER by MX, the
-pol null cells are still
considerably more sensitive than wild-type cells (Fig. 7). These data
are consistent with a role of
-pol-dependent long patch
BER, in addition to
-pol-dependent single-nucleotide repair, in the protection of cells against methylation-induced cytotoxicity. In these experiments in wild-type cells, appreciable protection against cytotoxicity by
-pol-dependent long
patch repair was seen in the absence of
-pol-dependent
single-nucleotide repair. In contrast, experiments to quantitate repair
in vitro demonstrate that single-nucleotide BER predominates
over long patch repair in wild-type cell extracts. These results
suggest that
-pol-dependent long patch repair can be
up-regulated to compensate for a cellular deficiency in
-pol-dependent single-nucleotide repair.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Brian J. Vande Berg
for assistance with the PhosphorImager analysis, Dr. Robert W. Sobol
for help with the SV40-transformation of the Xpa mouse
fibroblasts, and Dr. William A. Beard for helpful discussion during the
course of this work. We thank Drs. Thomas A. Kunkel, Wendy P. Osheroff,
Bennett Van Houten, and William A. Beard for critical reading of the manuscript.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Structural Biology, NIEHS, National Institutes of Health, 111 T. W. Alexander Dr., Research Triangle Park, NC 27709. Tel.: 919-541-3267; Fax: 919-541-2660; E-mail: wilson5@niehs.nih.gov.
2
R. W. Sobol, J. K. Horton, J. Nakamura, and J. A. Swenberg, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
BER, base excision
repair;
-pol, DNA polymerase
;
FEN1, flap endonuclease 1;
dRP, 5'-deoxyribose phosphate;
AP, apurinic/apyrimidinic;
APE, AP
endonuclease;
UDG, uracil-DNA glycosylase;
MX, methoxyamine;
MMS, methyl methanesulfonate;
MNU, methylnitrosourea;
DTT, dithiothreitol;
NER, nucleotide excision repair.
 |
REFERENCES |
| 1.
|
Matsumoto, Y.,
Kim, K.,
and Bogenhagen, D. F.
(1994)
Mol. Cell. Biol.
14,
6187-6197[Abstract/Free Full Text]
|
| 2.
|
Frosina, G.,
Fortini, P.,
Rossi, O.,
Carrozzino, F.,
Raspaglio, G.,
Cox, L. S.,
Lane, D. P.,
Abbondandolo, A.,
and Dogliotti, E.
(1996)
J. Biol. Chem.
271,
9573-9578[Abstract/Free Full Text]
|
| 3.
|
Wilson, S. H.
(1998)
Mutat. Res.
407,
203-215[Medline]
[Order article via Infotrieve]
|
| 4.
|
Srivastava, D. K.,
Vande Berg, B. J.,
Prasad, R.,
Molina, J. T.,
Beard, W. A.,
Tomkinson, A. E.,
and Wilson, S. H.
(1998)
J. Biol. Chem.
273,
21203-21209[Abstract/Free Full Text]
|
| 5.
|
Prasad, R.,
Singhal, R. K.,
Srivastava, D. K.,
Molina, J. T.,
Tomkinson, A. E.,
and Wilson, S. H.
(1996)
J. Biol. Chem.
271,
16000-16007[Abstract/Free Full Text]
|
| 6.
|
Sobol, R. W.,
Horton, J. K.,
Kuhn, R.,
Gu, H.,
Singhal, R. K.,
Prasad, R.,
Rajewsky, K.,
and Wilson, S. H.
(1996)
Nature
379,
183-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Teo, I. A.,
Arlett, C. F.,
Harcourt, S. A.,
Priestley, A.,
and Broughton, B. C.
(1983)
Mutat. Res.
107,
371-386[Medline]
[Order article via Infotrieve]
|
| 8.
|
Dianov, G.,
Price, A.,
and Lindahl, T.
(1992)
Mol. Cell. Biol.
12,
1605-1612[Abstract/Free Full Text]
|
| 9.
|
Klungland, A.,
and Lindahl, T.
(1997)
EMBO J.
16,
3341-3348[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Fortini, P.,
Parlanti, E.,
Sidorkina, O. M.,
Laval, J.,
and Dogliotti, E.
(1999)
J. Biol. Chem.
274,
15230-15236[Abstract/Free Full Text]
|
| 11.
|
Fortini, P.,
Pascucci, B.,
Parlanti, E.,
Sobol, R. W.,
Wilson, S. H.,
and Dogliotti, E.
(1998)
Biochemistry
37,
3575-3580[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Engelward, B. P.,
Dreslin, A.,
Christensen, J.,
Huszar, D.,
Kurahara, C.,
and Samson, L.
(1996)
EMBO J.
15,
945-952[Medline]
[Order article via Infotrieve]
|
| 13.
|
Cappelli, E.,
Taylor, R.,
Cevasco, M.,
Abbondandolo, A.,
Caldecott, K.,
and Frosina, G.
(1997)
J. Biol. Chem.
272,
23970-23975[Abstract/Free Full Text]
|
| 14.
|
Tebbs, R. S.,
Flannery, M. L.,
Meneses, J. J.,
Hartmann, A.,
Tucker, J. D.,
Thompson, L. H.,
Cleaver, J. E.,
and Pedersen, R. A.
(1999)
Dev. Biol.
208,
513-529[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Kim, K.,
Biade, S.,
and Matsumoto, Y.
(1998)
J. Biol. Chem.
273,
8842-8848[Abstract/Free Full Text]
|
| 16.
|
Satoh, M. S.,
and Lindahl, T.
(1992)
Nature
356,
356-358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Trucco, C.,
Oliver, F. J.,
de Murcia, G.,
and Menissier-de Murcia, J.
(1998)
Nucleic Acids Res.
26,
2644-2649[Abstract/Free Full Text]
|
| 18.
|
Stucki, M.,
Pascucci, B.,
Parlanti, E.,
Fortini, P.,
Wilson, S. H.,
Hubscher, U.,
and Dogliotti, E.
(1998)
Oncogene
17,
835-843[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Gary, R.,
Kim, K.,
Cornelius, H. L.,
Park, M. S.,
and Matsumoto, Y.
(1999)
J. Biol. Chem.
274,
4354-4363[Abstract/Free Full Text]
|
| 20.
|
Biade, S.,
Sobol, R. W.,
Wilson, S. H.,
and Matsumoto, Y.
(1998)
J. Biol. Chem.
273,
898-902[Abstract/Free Full Text]
|
| 21.
|
Dianov, G. L.,
Prasad, R.,
Wilson, S. H.,
and Bohr, V. A.
(1999)
J. Biol. Chem.
274,
13741-13743[Abstract/Free Full Text]
|
| 22.
| Prasad, R., Dianov, G. L., Bohr, V. A., and Wilson, S. H. (2000) J. Biol. Chem. 275, in press
|
| 23.
|
Beard, W. A.,
and Wilson, S. H.
(1995)
Methods Enzymol.
262,
98-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Strauss, P. R.,
Beard, W. A.,
Patterson, T. A.,
and Wilson, S. H.
(1997)
J. Biol. Chem.
272,
1302-1307[Abstract/Free Full Text]
|
| 25.
|
Slupphaug, G.,
Eftedal, I.,
Kavli, B.,
Bharati, S.,
Helle, N. M.,
Haug, T.,
Levine, D. W.,
and Krokan, H. E.
(1995)
Biochemistry
34,
128-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Singhal, R. K.,
Prasad, R.,
and Wilson, S. H.
(1995)
J. Biol. Chem.
270,
949-957[Abstract/Free Full Text]
|
| 27.
|
Ochs, K.,
Sobol, R. W.,
Wilson, S. H.,
and Kaina, B.
(1999)
Cancer Res.
59,
1544-1551[Abstract/Free Full Text]
|
| 28.
|
de Vries, A.,
and van Steeg, H.
(1996)
Semin. Cancer Biol.
7,
229-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Sandigursky, M.,
Freyer, G. A.,
and Franklin, W. A.
(1998)
Nucleic Acids Res.
26,
1282-1287[Abstract/Free Full Text]
|
| 30.
|
Butler, W. B.
(1984)
Anal. Biochem.
141,
70-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Liuzzi, M.,
and Talpaert-Borle, M.
(1985)
J. Biol. Chem.
260,
5252-5258[Abstract/Free Full Text]
|
| 32.
|
Rosa, S.,
Fortini, P.,
Karran, P.,
Bignami, M.,
and Dogliotti, E.
(1991)
Nucleic Acids Res.
19,
5569-5574[Abstract/ |